Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Change in Interest Receivables (2023 - 2025)

Prokidney (PROK) has disclosed Change in Interest Receivables for 3 consecutive years, with -$538000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Interest Receivables fell 122.85% to -$538000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.9 million, a 188.08% decrease, with the full-year FY2024 number at $1.1 million, down 22.04% from a year prior.
  • Change in Interest Receivables was -$538000.0 for Q3 2025 at Prokidney, down from $23000.0 in the prior quarter.
  • In the past five years, Change in Interest Receivables ranged from a high of $5.5 million in Q1 2023 to a low of -$7.4 million in Q3 2023.
  • A 3-year average of $112454.5 and a median of $529000.0 in 2024 define the central range for Change in Interest Receivables.
  • Biggest YoY gain for Change in Interest Receivables was 131.93% in 2024; the steepest drop was 501.82% in 2024.
  • Prokidney's Change in Interest Receivables stood at $661000.0 in 2023, then crashed by 501.82% to -$2.7 million in 2024, then soared by 79.74% to -$538000.0 in 2025.
  • Per Business Quant, the three most recent readings for PROK's Change in Interest Receivables are -$538000.0 (Q3 2025), $23000.0 (Q2 2025), and -$695000.0 (Q1 2025).